Andrew E. Esch, MD, MBA, discusses the need for systemic reforms to support pharmacist-led medication optimization in palliative and community-based care.
Andrew E. Esch, MD, MBA
Advertisement
Articles by Andrew E. Esch, MD, MBA
Advertisement
Latest Updated Articles
When Less Is More: Addressing Polypharmacy in High-Risk PopulationsPublished: July 7th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
Improving Outcomes in Diffuse B-Cell Lymphoma Requires Multidisciplinary Evolution
3
Key Data, Interviews at the 2025 ASH Annual Meeting and Exposition
4
Long-Term BENEFIT Data Affirm Isa-VRd as Standard of Care in Transplant-Ineligible NDMM
5
